Products

Eko Analysis Software
Eko Devices
Cardiology AI
Eko Analysis Software is an FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation.
Eko Murmur Analysis Software (EMAS)
Eko Devices
Cardiology AI
Eko Murmur Analysis Software (EMAS) is an FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease.

See all 2 products →

About Eko Devices

Eko Health (formerly Eko Devices) is a leading digital health company that is transforming cardiovascular and pulmonary care through its innovative AI-powered platform. The company develops advanced digital stethoscopes that amplify and filter heart and lung sounds, providing clinicians with enhanced clarity in physical exams, even in noisy environments. These devices integrate with a mobile application, allowing for the visualization, recording, and secure sharing of patient auscultation data, which can be seamlessly integrated into electronic health records (EHRs).

Eko’s platform is further enhanced by FDA-cleared artificial intelligence algorithms designed to aid in the early detection of critical cardiac conditions. These algorithms can identify signs of atrial fibrillation, heart murmurs indicative of structural heart disease, and low ejection fraction, offering point-of-care decision support to healthcare professionals. By leveraging AI-powered insights, Eko aims to improve diagnostic accuracy, streamline clinical workflows, and facilitate timely interventions for patients with often underdiagnosed and undertreated heart and lung diseases.

Beyond in-clinic use, Eko’s technology supports telehealth and remote patient monitoring, enabling clinicians to perform virtual physical exams and continuously track cardiopulmonary health. This comprehensive approach empowers physicians, nurse practitioners, and physician assistants to provide more precise, proactive, and accessible care, ultimately leading to improved patient outcomes and a more efficient healthcare delivery system.

Focus Areas

Digital stethoscopes AI software for cardiovascular disease detection AI software for pulmonary disease detection heart murmurs atrial fibrillation low ejection fraction telehealth remote patient monitoring cardiac screening lung sound analysis

Business Intelligence

Key InvestorsArtis Ventures, Highland Capital Partners, Questa Capital, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, Double Point Ventures, EDBI, LG Technology Ventures
Partnerships3M Littmann, AstraZeneca, National Association of Free & Charitable Clinics, Health Recovery Solutions (HRS), FIGS, Astellas Pharma Inc., Welldoc, Inc., Imperial College London, Mayo Clinic, Impilo, The Digital Health Store, Wayne General Hospital
TechnologyAI-powered, cloud-based machine learning algorithms, digital stethoscopes (Eko CORE, Eko DUO, Eko CORE 500), mobile application, signal processing, convolutional neural networks, cardiac foundation model (EFAST), Sensora Cardiac Early Detection Platform, active noise cancellation, 3-lead ECG
FDA Clearances9 cleared products (estimated)

What Physicians Need to Know

Digital Stethoscopes
Eko offers a range of digital stethoscopes, including the CORE, DUO (with integrated 1-lead ECG), 3Mu2122 Littmannu00ae CORE, and the advanced CORE 500u2122 (with 3-lead ECG and onboard display). These devices provide up to 40x sound amplification and active noise cancellation for clearer auscultation in various environments.
AI-Powered Disease Detection
Eko specializes in FDA-cleared AI software for the early detection of cardiovascular diseases, including heart murmurs, atrial fibrillation (AFib), and low ejection fraction (LVEF u226440%). Their SENSORAu00ae platform also supports clinicians in identifying structural murmurs and low ejection fraction during physical exams. They are also developing AI for pulmonary hypertension detection.
Telehealth & Remote Monitoring
Eko provides comprehensive telehealth solutions, enabling live streaming of heart and lung sounds, phonocardiograms (PCGs), and ECG waveforms during virtual visits. The Eko DUO is designed for patient home use under provider supervision, facilitating remote cardiac and pulmonary exams and monitoring.
Cardiac & Lung Sound Analysis
The technology enhances the ability to analyze heart and lung sounds with high fidelity, offering real-time waveform visualizations and automatic record-keeping. This supports the detection of subtle signs of heart and lung disease, including crackles, rhonchi, or rales associated with pulmonary conditions.
Key Differentiators
Eko's key differentiators include multiple FDA clearances for its AI algorithms, the integration of digital stethoscope and ECG capabilities in a single device, superior audio quality with noise cancellation, real-time visual feedback of heart sounds and ECG, and extensive clinical validation in peer-reviewed publications. Their SENSORAu00ae platform offers an enterprise-level solution for health systems.
Technology Stack
Eko's technology stack comprises advanced digital stethoscopes, AI/machine learning algorithms for disease detection, mobile applications (iOS and Android) for data visualization and analysis, cloud-based data storage (HIPAA compliant and SOC2 certified), Bluetooth connectivity, and a robust suite of APIs and SDKs for seamless integration with EHR and telehealth platforms.
Physician Tip

For physicians, Eko Devices stands out by transforming routine physical exams into opportunities for earlier and more accurate disease detection. The FDA-cleared AI acts as a 'second set of eyes,' enhancing clinical expertise and providing objective data through real-time ECG and waveform visualizations. This leads to more confident clinical decisions, reduced diagnostic uncertainty, and expedited referrals, especially in primary care settings. The enhanced audio clarity, even in noisy environments, and the ability to conduct thorough virtual exams via telehealth, significantly improve patient care and engagement by allowing real-time sharing of findings. Eko's solutions are designed to integrate seamlessly into existing workflows, minimizing disruption while maximizing diagnostic capability across various specialties.

Eko offers robust integration capabilities with existing telehealth solutions and Electronic Health Record (EHR) systems. Their Eko Connect suite provides SDKs and APIs for seamless live streaming of auscultation and ECG data, ensuring compatibility with various digital health platforms. Eko's EHR integration allows for automatic pushing of PDF reports or anonymous URLs to patient charts, and enables single sign-on for launching telehealth sessions directly from the EHR, simplifying workflow and data management. Eko has partnered with platforms like Caregility and Health Recovery Solutions (HRS) to embed their smart stethoscope technology into virtual care and remote patient monitoring programs.

Products by Eko Devices

2 products in the directory

Eko Analysis Software
Eko Devices
Cardiology AI
Eko Analysis Software is an FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation.
Eko Murmur Analysis Software (EMAS)
Eko Devices
Cardiology AI
Eko Murmur Analysis Software (EMAS) is an FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease.

What the Web Says

Eko Devices generally receives positive reviews for its digital stethoscopes, particularly the Eko CORE 500, which is praised for its sound amplification, noise cancellation, and integrated ECG capabilities. Many healthcare professionals, especially those with hearing loss or working in noisy environments, find the devices to be a significant improvement over traditional stethoscopes. However, some users express concerns about data privacy, subscription fees for advanced features, and occasional issues with device durability or app functionality.

Overall: Positive

Strengths

  • Excellent sound amplification and clarity, especially for heart and lung sounds.
  • Effective active noise cancellation, beneficial in loud clinical settings.
  • Integrated ECG and AI-powered detection for murmurs and arrhythmias (with subscription).
  • Ability to record and share auscultation sounds for educational or consultation purposes.
  • Compact, easy to disinfect, and portable design.
  • Helpful for healthcare professionals with hearing difficulties.

Limitations

  • Concerns about data harvesting and privacy due to required professional email/NPI and inability to delete payment methods.
  • Subscription fees for access to key features like AFib and murmur detection.
  • Occasional issues with Bluetooth connectivity and app functionality, including battery drain.
  • Some users reported durability issues, such as earpieces failing or charging ports breaking.
  • Can be heavier and bulkier than traditional stethoscopes.
  • EKG may not work well on hairy chests, and some find the EKG feature gimmicky.

Based on reviews from: Reddit (r/medicine, r/emergencymedicine, r/FamilyMedicine, r/physicianassistant, r/IntensiveCare, r/Residency), Apple App Store, Eko Health Website, The Medical Futurist, ChicFitWorld, Nurse Lizzie Reviews, REVIEWS.io, iMedicalApps, YouTube (Eko digital stethoscope Gen 1 vs Gen 2 Review and Comparison for Use in Infectious Patients, Eko Core Stethoscope Review with Noise Cancellation), Health Innovation North East North Cumbria (HI NENC)

Last updated: 2026-07-18

Videos

News, demos, and interviews about Eko Devices.

Loading videos...

Videos load interactively. If none appear, search YouTube for Eko Devices →

View all on YouTube

Press & Coverage

MedTech Dive
Eko wins FDA nod for AI to detect sign of heart failure using stethoscope
Eko Health received FDA 510(k) clearance for a stethoscope feature that can detect low ejection fraction (EF), an indicator of heart failure, during routine physical examinations. This AI-powered tool aims to improve early detection of heart failure in primary care settings.
2024-04
Medical Device Network
Eko Health raises $41M to expand its AI-based diagnostic tools
Eko Health secured $41 million in Series D funding to scale its AI-powered heart and lung disease detection platform, building on recent FDA clearances for its structural heart murmur and low ejection fraction detection algorithms. The funding will support expansion in the US and internationally.
2024-06
Fierce Biotech
Eko Health captures $41M to expand AI stethoscope business worldwide
Eko Health raised $41 million in Series D financing to expand its commercial reach in the U.S. and overseas, following an FDA clearance for its AI program to detect low cardiac ejection fraction. The company aims to update the stethoscope as a connected medical device for early heart and lung disease detection.
2024-06
AJMC
FDA Approves AI Stethoscope for Earlier Heart Failure Detection
The FDA approved Eko Health's AI-embedded stethoscope for earlier detection of heart failure by identifying low ejection fraction in 15 seconds during routine checkups. This innovation, developed with Mayo Clinic, aims to address the challenge of undiagnosed heart failure cases.
2024-04
PR Newswire
AI-Enabled Eko Health Stethoscope TRICORDER Trial Marks Historic Leap in Early Heart Disease Detection
The TRICORDER study, published in The Lancet, demonstrated that Eko Health's AI-enabled digital stethoscope significantly increased the detection of heart failure, atrial fibrillation, and valvular heart disease in primary care settings. This large-scale NHS trial highlights the real-world impact of AI-assisted stethoscope exams.
2026-01
Eko Health (Press Release)
Eko Health Broadens Global Reach with UK Launch of AI-Powered Stethoscope Platform
Eko Health announced its launch in the United Kingdom, making its CORE 500u2122 Digital Stethoscope, Eko+ Membership, and accessories available to UK clinicians. This expansion aims to provide AI-powered tools for earlier detection of cardiovascular and respiratory diseases.
2025-04
Eko Health (Press Release)
Eko Hits Milestone Number of Stethoscopes Sold
Eko Health announced selling 750,000 digital stethoscopes worldwide, indicating a rapid adoption of digital stethoscopes over traditional analog devices. The company highlights that providers using Eko are twice as likely to detect heart disease.
2026-05
Eko Health (Press Release)
Astellas and Eko Health Announce Agreement to Incorporate Next Generation Eko CORE 500 TM Digital Stethoscope into Z1608, an Innovative Solution Under Development for Heart Failure Patients Built on Welldoc's Proven Digital Therapeutic Platform
Astellas Pharma Inc. and Eko Health Inc. announced a License & Supply Agreement to integrate Eko's CORE 500u2122 digital stethoscope and AI-powered software into Z1608, a digital therapeutic solution for heart failure patients being developed with Welldoc.
2023-07

Frequently Asked Questions

Eko's FDA-cleared AI algorithms on the Sensora platform are designed to detect structural heart murmurs, atrial fibrillation (AFib), and low ejection fraction (Low EF) from heart sounds and ECGs. For structural heart murmurs, studies show high sensitivity and specificity, with one algorithm demonstrating 93% sensitivity and 91% specificity, and another doubling detection rates compared to conventional practice. For AFib, Eko's AI has shown 95% sensitivity and 94% specificity, while for Low EF (LVEF < 40%), it has achieved 85% sensitivity and 70% specificity. Eko also has an algorithm for pulmonary hypertension detection, showing 71% sensitivity and 73% specificity in studies.
Eko's digital stethoscopes seamlessly replace traditional ones, offering amplified sounds and noise cancellation, while the AI analyzes heart and ECG data in real-time. The platform integrates with major EHR systems, allowing clinicians to view AI analysis, push results to patient charts via PDF or URL, and launch telehealth sessions directly from within their EHR. Eko's Telehealth platform also enables high-fidelity auscultation and ECG live-streaming during virtual visits, supporting remote patient monitoring across various care settings.
Eko's digital stethoscopes and AI algorithms have received multiple FDA clearances for their intended uses, including the detection of structural heart murmurs, atrial fibrillation, and low ejection fraction. The Eko Cloud, used for secure data storage, is HIPAA compliant and SOC2 certified, ensuring data security and regulatory adherence.
Eko offers various pricing models, including device purchases and subscription-based access to its AI software, often tailored for different organizational needs. A significant ROI driver is the recent establishment of a CMS payment rate of $128.90 per use for Eko Health's Sensora platform, along with a Category III CPT code effective July 1, 2025, creating a clear reimbursement pathway for AI-enabled cardiac analysis. This facilitates earlier disease detection, potentially reducing specialist referrals and improving patient outcomes.
Eko provides comprehensive training resources, including online modules, webinars, video tutorials, and a dedicated Help Center with user manuals and FAQs. For enterprise clients, Eko offers support for program administration and system integration, ensuring effective implementation and utilization. The Eko+ membership also enhances clinical training with real-time feedback and detailed AI analysis.
Eko actively partners with leading healthcare technology providers and health systems to enhance interoperability and integrate its solutions into broader care ecosystems. Examples include integrations with Health Recovery Solutions (HRS) for remote patient monitoring and Caregility for telehealth platforms, enabling seamless data flow and comprehensive virtual physical exams. Eko also collaborates with institutions like Mayo Clinic on algorithm development.
Founded in 2013, Eko Health is a well-established private company that has raised over $327 million in funding, demonstrating strong investor confidence. Its FDA-cleared platform is used by over 500,000 healthcare professionals and integrated into health systems operating over 800 U.S. hospitals, indicating significant market adoption and stability. Eko is continuously advancing its AI for early disease detection, with a vision to transform routine physical exams into powerful cardiac and pulmonary screening opportunities.

Investors

Who's funded Eko Devices.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.